IL-8RB Antibodies

Santa Cruz Biotechnology features a diverse variety of IL-8RB monoclonal antibodies for research focused on understanding IL-8 receptor functions in biological processes. IL-8RB monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The IL-8 receptor, also known as IL-8RB, plays a central role in mediating the effects of interleukin-8, a key chemokine involved in the inflammatory response. By binding to IL-8, IL-8RB facilitates the recruitment of immune cells to sites of inflammation, making it essential for both innate and adaptive immunity. Understanding IL-8RB function is crucial for elucidating mechanisms underlying various diseases, including cancer and chronic inflammatory conditions. IL-8RB monoclonal antibodies enable researchers to explore signaling pathways associated with inflammation and immune responses. Investigating IL-8RB expression patterns helps reveal its involvement in disease progression and potential therapeutic targets. Studying IL-8RB interactions with other molecules provides insights into inflammatory cascade regulation. Santa Cruz Biotechnology monoclonal antibodies for IL-8RB support researchers worldwide in advancing immunology research and therapeutic development.